Last updated on January 2017

A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia (STRENGTH)


Brief description of study

A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia (STRENGTH)

Detailed Study Description

Receive EpaNova for the treatment of high triglycerides

Clinical Study Identifier: TX147225

Find a site near you

Start Over

Clinical Research of South Florida

370 Minorca Avenue Coral Gables, FL USA
  Connect »